Unraveling The Controversy Over The CRISPR Mutations Study – Fast Company
Fast Company |
Unraveling The Controversy Over The CRISPR Mutations Study
Fast Company Cas9, the CRISPR enzyme that snips DNA, in contact with its target. [Graph: via rcsb.org] A central promise of CRISPR-based gene editing is its ability to pinpoint particular genes. But if this technology produces dangerous side effects by creating … A World First CRISPR Trial Will Edit Genes Inside the Human Body One of Crispr's Creators Faces Her Fears From AAV to CRISPR: Era of hacking our bodies is just beginning |
